JP2011509926A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509926A5
JP2011509926A5 JP2010538713A JP2010538713A JP2011509926A5 JP 2011509926 A5 JP2011509926 A5 JP 2011509926A5 JP 2010538713 A JP2010538713 A JP 2010538713A JP 2010538713 A JP2010538713 A JP 2010538713A JP 2011509926 A5 JP2011509926 A5 JP 2011509926A5
Authority
JP
Japan
Prior art keywords
amino acid
polypeptide
modified polypeptide
acid residues
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010538713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509926A (ja
JP5745275B2 (ja
Filing date
Publication date
Priority claimed from US12/002,972 external-priority patent/US8937047B2/en
Application filed filed Critical
Publication of JP2011509926A publication Critical patent/JP2011509926A/ja
Publication of JP2011509926A5 publication Critical patent/JP2011509926A5/ja
Application granted granted Critical
Publication of JP5745275B2 publication Critical patent/JP5745275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010538713A 2007-12-19 2008-12-17 迅速クリアランスポリペプチドの生体内動態 Active JP5745275B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/002,972 2007-12-19
US12/002,972 US8937047B2 (en) 2007-12-19 2007-12-19 Biokinetics of fast-clearing polypeptides
PCT/EP2008/067774 WO2009077569A1 (en) 2007-12-19 2008-12-17 Biokinetics of fast-clearing polypeptides

Publications (3)

Publication Number Publication Date
JP2011509926A JP2011509926A (ja) 2011-03-31
JP2011509926A5 true JP2011509926A5 (cg-RX-API-DMAC7.html) 2013-01-31
JP5745275B2 JP5745275B2 (ja) 2015-07-08

Family

ID=40591871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010538713A Active JP5745275B2 (ja) 2007-12-19 2008-12-17 迅速クリアランスポリペプチドの生体内動態

Country Status (7)

Country Link
US (1) US8937047B2 (cg-RX-API-DMAC7.html)
EP (1) EP2231706B3 (cg-RX-API-DMAC7.html)
JP (1) JP5745275B2 (cg-RX-API-DMAC7.html)
CN (1) CN101952314B (cg-RX-API-DMAC7.html)
AT (1) ATE529445T1 (cg-RX-API-DMAC7.html)
ES (1) ES2375018T7 (cg-RX-API-DMAC7.html)
WO (1) WO2009077569A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9187535B2 (en) * 2007-12-19 2015-11-17 Affibody Ab Polypeptide derived from protein A and able to bind PDGF
US8937047B2 (en) * 2007-12-19 2015-01-20 General Electric Company Biokinetics of fast-clearing polypeptides
US8124725B2 (en) * 2007-12-19 2012-02-28 General Electric Company PDGF-Rβ binders
EP2077272A1 (en) * 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
EP2072525A1 (en) 2007-12-21 2009-06-24 Affibody AB New polypeptides having affinity for HER2
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
US10861978B2 (en) 2012-04-02 2020-12-08 Samsung Display Co., Ltd. Display device
CN112870390B (zh) * 2021-01-29 2022-04-22 四川大学华西医院 一种镓68标记的亲合体蛋白pet显像剂及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322678A (en) 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US6673559B1 (en) 1989-12-27 2004-01-06 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Met proto-oncogene and a method for predicting breast cancer progression
US6271364B1 (en) 1999-02-23 2001-08-07 Amgen Inc. Analogs of NT-3
US6020163A (en) 1997-08-06 2000-02-01 Zymogenetics, Inc. Lipocalin homolog
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
US7118915B2 (en) 2001-09-27 2006-10-10 Pieris Proteolab Ag Muteins of apolipoprotein D
US20060008844A1 (en) 2004-06-17 2006-01-12 Avidia Research Institute c-Met kinase binding proteins
EP3127921A1 (en) 2007-09-26 2017-02-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substition in cdr
KR20150126724A (ko) 2007-09-28 2015-11-12 추가이 세이야쿠 가부시키가이샤 혈장 중 반응속도가 개선된 항-글리피칸-3 항체
US8937047B2 (en) * 2007-12-19 2015-01-20 General Electric Company Biokinetics of fast-clearing polypeptides
US8124725B2 (en) * 2007-12-19 2012-02-28 General Electric Company PDGF-Rβ binders

Similar Documents

Publication Publication Date Title
JP2020073472A5 (cg-RX-API-DMAC7.html)
JP2009537624A5 (cg-RX-API-DMAC7.html)
JP2024503635A (ja) 線維芽細胞活性化タンパク質リガンドを含む化合物およびその使用
JP2009500431A5 (cg-RX-API-DMAC7.html)
JP2008511557A5 (cg-RX-API-DMAC7.html)
JP4948742B2 (ja) ペプチド系化合物
JP2016052315A5 (cg-RX-API-DMAC7.html)
JP2011525354A5 (cg-RX-API-DMAC7.html)
JP2018508492A5 (cg-RX-API-DMAC7.html)
JP2009519013A5 (cg-RX-API-DMAC7.html)
JP2014224121A5 (cg-RX-API-DMAC7.html)
JP2009533317A5 (cg-RX-API-DMAC7.html)
JP2014520120A5 (cg-RX-API-DMAC7.html)
JP6979180B2 (ja) 診断及び治療のための、改善された薬物動態及びコレシストキニン−2受容体(cck2r)への標的化
RU2004122695A (ru) Мечение галлием-68 и галлием-67 средств для направленной доставки
KR20250073273A (ko) 고순도 구리 방사성 의약 조성물 및 이의 진단 및 치료 용도
JP2014526881A5 (cg-RX-API-DMAC7.html)
WO2017150549A1 (ja) 放射性標識薬剤
JP2022502347A (ja) 細胞透過性ペプチド
Singh et al. Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency
Kunstler et al. Organometallic 99mTc (III)‘4+ 1'Bombesin (7− 14) Conjugates: Synthesis, Radiolabeling, and in Vitro/in Vivo Studies
JP2020526497A5 (cg-RX-API-DMAC7.html)
JP2009500298A5 (cg-RX-API-DMAC7.html)
JP5745275B2 (ja) 迅速クリアランスポリペプチドの生体内動態
JP2010502585A5 (cg-RX-API-DMAC7.html)